StockData
PAVmed Inc. logo

PAVmed Inc. (PAVM) stock

PAVMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$1.32−0.19 (-12.58%)

Close on Nov 18, 2026Market cap $10.55MP/E –Yield –

PAVmed revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

PAVmed's revenue for the twelve months ending Jun 30, 2026 was $112.00K, down 89.0% year over year. For fiscal 2025 it was $71.00K, down 97.6% from the year before. The highest annual figure on record is $3.00M in fiscal 2024.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$71.00K-97.6%
FY2024Dec 31, 2024$3.00M+22.1%
FY2023Dec 31, 2023$2.45M+550.4%
FY2022Dec 31, 2022$377.00K-24.6%
FY2021Dec 31, 2021$500.00K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$33.00K+450.0%
Q1 FY2026Mar 31, 2026$22.00K+175.0%
Q4 FY2025Dec 31, 2025$52.00K+420.0%
Q3 FY2025Sep 30, 2025$5.00K-99.5%
Q2 FY2025Jun 30, 2025$6.00K-99.4%
Q1 FY2025Mar 31, 2025$8.00K-99.2%
Q4 FY2024Dec 31, 2024$10.00K-99.0%
Q3 FY2024Sep 30, 2024$996.00K+25.9%
Q2 FY2024Jun 30, 2024$979.00K+489.8%
Q1 FY2024Mar 31, 2024$1.01M+126.5%
Q4 FY2023Dec 31, 2023$1.05M+836.6%
Q3 FY2023Sep 30, 2023$791.00K+940.8%
Q2 FY2023Jun 30, 2023$166.00K–
Q1 FY2023Mar 31, 2023$446.00K+136.0%
Q4 FY2022Dec 31, 2022$112.00K-62.7%
Q3 FY2022Sep 30, 2022$76.00K-62.0%
Q2 FY2022Jun 30, 2022$0–
Q1 FY2022Mar 31, 2022$189.00K–
Q4 FY2021Dec 31, 2021$300.00K–
Q3 FY2021Sep 30, 2021$200.00K–

More PAVmed figures

See a number that looks wrong?